Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M, Calabrò P, Fulgheri PL, Bucci M, Berra S, Villani GQ, Vladoianu M, Popescu E, Velican VG, Pirvu O. Modesti PA, et al. Among authors: calabro p. J Hypertens. 2016 Mar;34(3):576-87; discussion 587. doi: 10.1097/HJH.0000000000000805. J Hypertens. 2016. PMID: 26703917 Clinical Trial.
[Optimal therapeutic management in the clinical journey of patients with heart failure].
Ameri P, Amico AF, Battagliese A, Berra S, Calabrò P, Candela M, Clemenza F, Desideri G, Di Tano G, Gallucci F, Gardin A, Iacoviello M, Leonardi G, Morgagni R, Mortara A, Palazzuoli A, Paolillo S, Filardi PP, Volpe M. Ameri P, et al. Among authors: calabro p. G Ital Cardiol (Rome). 2020 Dec;21(12 Suppl 1):e3-e15. doi: 10.1714/3479.34615. G Ital Cardiol (Rome). 2020. PMID: 33239823 Italian.
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey.
D'Erasmo L, Gallo A, Cefalù AB, Di Costanzo A, Saheb S, Giammanco A, Averna M, Buonaiuto A, Iannuzzo G, Fortunato G, Puja A, Montalcini T, Pavanello C, Calabresi L, Vigna GB, Bucci M, Bonomo K, Nota F, Sampietro T, Sbrana F, Suppressa P, Sabbà C, Fimiani F, Cesaro A, Calabrò P, Palmisano S, D'Addato S, Pisciotta L, Bertolini S, Bittar R, Kalmykova O, Béliard S, Carrié A, Arca M, Bruckert E. D'Erasmo L, et al. Among authors: calabro p. Orphanet J Rare Dis. 2021 Sep 8;16(1):381. doi: 10.1186/s13023-021-01999-8. Orphanet J Rare Dis. 2021. PMID: 34496902 Free PMC article.
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy.
D'Erasmo L, Cefalù AB, Noto D, Giammanco A, Averna M, Pintus P, Medde P, Vigna GB, Sirtori C, Calabresi L, Pavanello C, Bucci M, Sabbà C, Suppressa P, Natale F, Calabrò P, Sampietro T, Bigazzi F, Sbrana F, Bonomo K, Sileo F, Arca M. D'Erasmo L, et al. Among authors: calabro p. Adv Ther. 2017 May;34(5):1200-1210. doi: 10.1007/s12325-017-0531-x. Epub 2017 Apr 21. Adv Ther. 2017. PMID: 28432645
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience.
Sperlongano S, Gragnano F, Natale F, D'Erasmo L, Concilio C, Cesaro A, Golia E, Crisci M, Sperlongano R, Fimiani F, Russo M, Arca M, Limongelli G, Calabrò P. Sperlongano S, et al. Among authors: calabro p. J Cardiovasc Med (Hagerstown). 2018 Mar;19(3):83-90. doi: 10.2459/JCM.0000000000000620. J Cardiovasc Med (Hagerstown). 2018. PMID: 29389816
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies.
Cesaro A, Schiavo A, Moscarella E, Coletta S, Conte M, Gragnano F, Fimiani F, Monda E, Caiazza M, Limongelli G, D'Erasmo L, Riccio C, Arca M, Calabrò P. Cesaro A, et al. Among authors: calabro p. J Cardiovasc Med (Hagerstown). 2021 Mar 1;22(3):151-161. doi: 10.2459/JCM.0000000000001077. J Cardiovasc Med (Hagerstown). 2021. PMID: 32858625 Review.
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia.
Cesaro A, Fimiani F, Gragnano F, Moscarella E, Schiavo A, Vergara A, Akioyamen L, D'Erasmo L, Averna M, Arca M, Calabrò P. Cesaro A, et al. Among authors: calabro p. Heart Fail Clin. 2022 Jan;18(1):177-188. doi: 10.1016/j.hfc.2021.07.008. Epub 2021 Oct 22. Heart Fail Clin. 2022. PMID: 34776078 Review.
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-Shiba M, Blom DJ, Raal FJ, Cuchel M; Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Tromp TR, et al. Lancet. 2022 Feb 19;399(10326):719-728. doi: 10.1016/S0140-6736(21)02001-8. Epub 2022 Jan 28. Lancet. 2022. PMID: 35101175 Free PMC article.
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group.
Pederiva C, Capra ME, Biasucci G, Banderali G, Fabrizi E, Gazzotti M, Casula M, Catapano AL; LIPIGEN Paediatric Group; MEMBERS OF THE LIPIGEN STEERING COMMITTEE; Arca M, Averna M, Bertolini S, Calandra S, Catapano AL, Tarugi P; PRINCIPAL INVESTIGATORS; Coordinator center; Pellegatta F; Participant Centers; Participant COLLABORATORS; STUDY COORDINATING GROUP. Pederiva C, et al. Atherosclerosis. 2022 May;349:233-239. doi: 10.1016/j.atherosclerosis.2022.04.021. Epub 2022 Apr 25. Atherosclerosis. 2022. PMID: 35562202
530 results